首页 | 本学科首页   官方微博 | 高级检索  
     


Nitric oxide‐mediated regulation of ‐amyloid clearance via alterations of MMP‐9/TIMP‐1
Authors:Lisa A. Ridnour  Sneha Dhanapal  Michael Hoos  Joan Wilson  Jennifer Lee  Robert Y. S. Cheng  Ernst E. Brueggemann  Harry B. Hines  Donna M. Wilcock  Michael P. Vitek  David A. Wink  Carol A. Colton
Affiliation:1. Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, , Bethesda, MD, USA;2. Division of Neurology, School of Medicine, Duke University, , Durham, NC, USA;3. Integrated Division of Toxicology, USAMRID, , Fort Detrick‐Frederick, MD, USA
Abstract:Fibrillar amyloid plaques are largely composed of amyloid‐beta (Aβ) peptides that are metabolized into products, including Aβ1‐16, by proteases including matrix metalloproteinase 9 (MMP‐9). The balance between production and degradation of Aβ proteins is critical to amyloid accumulation and resulting disease. Regulation of MMP‐9 and its endogenous inhibitor tissue inhibitor of metalloproteinase (TIMP)‐1 by nitric oxide (NO) has been shown. We hypothesize that nitric oxide synthase (NOS2) protects against Alzheimer's disease pathology by increasing amyloid clearance through NO regulation of MMP‐9/TIMP‐1 balance. We show NO‐mediated increased MMP‐9/TIMP‐1 ratios enhanced the degradation of fibrillar Aβ in vitro, which was abolished when silenced for MMP‐9 protein translation. The in vivo relationship between MMP‐9, NO and Aβ degradation was examined by comparing an Alzheimer's disease mouse model that expresses NOS2 with a model lacking NOS2. To quantitate MMP‐9 mediated changes, we generated an antibody recognizing the Aβ1‐16 fragment, and used mass spectrometry multi‐reaction monitoring assay for detection of immunoprecipitated Aβ1‐16 peptides. Aβ1‐16 levels decreased in brain lysates lacking NOS2 when compared with strains that express human amyloid precursor protein on the NOS2 background. TIMP‐1 increased in the APPSwDI/NOS2?/? mice with decreased MMP activity and increased amyloid burden, thereby supporting roles for NO in the regulation of MMP/TIMP balance and plaque clearance.
Keywords:amyloid  immunity  matrix metalloproteinase‐9 (MMP‐9)  microglia  nitric oxide (NOS2)  tissue inhibitor of metalloproteinase‐1 (TIMP‐1)
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号